Immunization, Vaccines and Biologicals

Influenza


Influenza vaccine research meetings

To monitor and review of research and development of influenza vaccines, IVR organizes 2 series of meetings:

1. WHO meeting on the development of influenza vaccines that induce broad spectrum and long-lasting immune responses

Second WHO meeting on the development of influenza vaccines that induce broad spectrum and long-lasting immune responses, 6-7 December 2005, WHO HQ Geneva

Third WHO meeting on the development of influenza vaccines that induce broad spectrum and long-lasting immune responses, 3-4 December 2007, WHO HQ Geneva

Fourth WHO meeting on the development of influenza vaccines that induce broad spectrum and long-lasting immune responses, London, 9-10 November 2009

Fifth WHO meeting on the development of influenza vaccines that induce broad spectrum and long-lasting immune responses, 16-17 November 2011, Geneva -

2. WHO meeting on evaluation of pandemic influenza prototype vaccine in clinical trials

WHO meeting on development and evaluation of influenza pandemic vaccines, 2-3 November 2005, WHO HQ Geneva

2nd WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials, 4-5 May 2006, WHO HQ, Geneva

3rd WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials, 15-16 February 2007, WHO HQ, Geneva

4th WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials, 14-15 February 2008, WHO HQ, Geneva

5th WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials, 12-13 February 2009, WHO HQ, Geneva

6th WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials, 18-19 February 2010, WHO, Geneva

7th WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials, 17-18 February 2011, WHO, Geneva

In 2011, IVR announced that it would combine its annual meeting on clinical trials evaluating pandemic influenza vaccines with its biennial meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses. The First WHO Integrated Meeting on development and clinical trials of Influenza vaccines that induce broadly protective and long-lasting immune responses will be organized in Hong Kong on 24-26 January 2013.

Share